Skip to main content
BMC Public Health logoLink to BMC Public Health
. 2024 Jul 31;24:2065. doi: 10.1186/s12889-024-19518-2

Night shift work and female breast cancer: a two-stage dose-response meta-analysis for the correct risk definition

Jinyoung Moon 1,2, Atsuko Ikeda-Araki 3,4, Yongseok Mun 5,
PMCID: PMC11293116  PMID: 39085800

Abstract

Introduction

The hypothesis of this study is night shift work exposure can increase the risk of female breast cancer. To validate this hypothesis, the authors conducted a two-stage dose-response meta-analysis with improved quality on this topic.

Methods

The medical librarian searched PubMed, EMBASE, and the Cochrane Library on December 30th, 2022. The eight inclusion criteria were determined and strictly applied to the selection process. A reliable dose-response meta-analysis methodology was applied.

Results

Reliable 10 cohort (total cases: 15,953, and total person-years: 6,812,138) and 11 case-control reports (total cases: 9196, and total controls:12,210) were included in the final analysis. The pooled risk ratio (RR) of female breast cancer (from cohort studies) for 1, 10, 20, and 30 years of night shift work exposure was 1.0042 (95% CI 1.0014–1.0070), 1.0425 (95% CI 1.0138–1.0719), 1.0867 (95% CI 1.0278–1.1490), and 1.1328 (95% CI 1.0419–1.2317), respectively. The pooled odds ratio (OR) of female breast cancer (from case-control studies) for 1, 10, 20, and 30 years of night shift work exposure was 1.0213 (95% CI 1.0108–1.0319), 1.2346 (95% CI 1.1129–1.3695), 1.5242 (95% CI 1.2386–1.8756), and 1.8817 (95% CI 1.3784–2.5687), respectively.

Discussion

This study has several strengths from the perspective of a dose-response meta-analysis: Strictly applied eight inclusion criteria, separately synthesized RRs from cohort studies and ORs from case-control studies, clearly defined exposure dose, years of night shift work for each risk estimate, a reliable dose-response meta-analysis methodology, and careful considering of selection, exposure, and outcome biases and confounder adjustment for each study. This careful consideration of potential biases and confounding led to the exclusion of unreliable two cohort and five case-control studies.

Supplementary Information

The online version contains supplementary material available at 10.1186/s12889-024-19518-2.

Keywords: Night shift work, Breast cancer, Dose-response meta-analysis, Cohort study, Case-control study

Introduction

The relationship between night shift work and breast cancer has been discussed in many previous studies. However, a definite conclusion was not made. In a systematic review and meta-analysis study by Van et al., the pooled risk ratio (RR) from cohort and nested case-control studies were 0.98 (95% CI 0.93–1.03) and 1.14 (95% CI 0.89–1.46), respectively, without statistical significance [1]. Only the pooled odds ratio (OR) from case-control studies was 1.34 (95% CI 1.17–1.53) with statistical significance. However, this study extracted only one representative risk estimate for night shift work versus day work from each study, and these risk estimates were synthesized to calculate pooled risk estimates. In a systematic review and meta-analysis study by Manouchehri et al., the pooled RR for the subjects with < 10 years of night shift work exposure was 1.13 (95% CI 1.03–1.24) with statistical significance. However, the pooled OR for the subjects with ≥ 10 years of night shift work exposure was 1.08 (95% CI 0.99–1.17) with statistical insignificance [2]. However, this study classified the exposure dose (years of night shift work) into only two categories, < 10 years and ≥ 10 years, and did not consider a dose-response relationship.

Even though the conclusions of individual articles and meta-analyses are divergent, the biological background for the association between night shift work and breast, prostate, and colorectal cancer is rather stable. The International Agency for Research on Cancer (IARC) classified night shift work as Group 2 A (probably carcinogenic) carcinogen for these three cancers. This indicates that night shift work has limited evidence of carcinogenicity in humans, sufficient evidence of carcinogenicity in experimental animals, and strong evidence that night shift work exhibits key characteristics of carcinogens [3]. National Toxicology Program (NTP) concluded that there is sufficient evidence of carcinogenicity between night shift work exposure and breast cancer, based on the collective body of cancer epidemiology and mechanistic studies in humans [4]. There are many studies supporting the biological background of this association [5]. Detailed potential biological mechanistic connections between night shift work and breast cancer are provided in Supplementary texts A.

Furthermore, many previous studies on the association between light exposure at night and breast cancer support a positive association between night shift work and breast cancer because the biological background mechanisms for these two topics are similar [68]. A detailed explanation for the rationale is provided in Supplementary texts B.

For the association between night shift work and breast cancer, several studies even reported an effect modification by the hormone receptor status of breast cancer. Detailed explanation is provided in Supplementary texts C.

The hypothesis of this study is that night shift work exposure can increase the risk of female breast cancer. To validate this hypothesis, the authors conducted a two-stage dose-response meta-analysis on this topic. Because of several methodologic flaws observed in previous meta-analysis studies, the authors strictly determined and applied the inclusion criteria and applied strict statistical principles to each process of the meta-analysis. Most importantly, the exposure dose for each risk estimate was clearly defined based on the texts of individual original articles. Finally, the authors applied a reliable two-stage dose-response meta-analysis methodology [9, 10]. Based on these efforts to improve the quality of this dose-response meta-analysis, this study could add to the existing body of evidence.

Methods

Literature search

A literature search was conducted by a medical librarian in the medical library of Inha University, Incheon, South Korea (information specialist Minji Kim commented on the acknowledgment section). The medical librarian searched PubMed, EMBASE, and the Cochrane Library on December 30th, 2022.

Inclusion criteria and selection of articles

The inclusion criteria were as follows: (i) the article should deal with the relationship between night shift work and breast cancer. (ii) The exposure of interest (night shift work) should be stated clearly in the text. Articles dealing with working experience in jobs that could be associated with night shift work as exposure of interest without a clear statement of night shift work were excluded because these jobs could not include night shift work in some cases. Articles dealing with light exposure at night, disturbance of the sleep-wake cycle, or the level of melatonin hormone as the exposure of interest were all excluded. Night shift work should be dealt with as occupational exposure, whether it was dealt with as a categorical or continuous variable. Variations in night shift work definition in each study were separately summarized in a table and considered in the evidence synthesis. (iii) Quantitative analysis should be included. The results should be provided as an RR or OR in cohort or case-control studies, respectively. Hazard ratio (HR) in survival analyses can be interpreted as RR based on the following previous studies [1113]. (iv) Literature written only in English was included. (v) Articles with only human subjects (not animal subjects) were included. (vi) For article type, only the original article was included. However, if all other criteria were met, a letter to the editor was also included after a careful examination. The abstract was excluded because research abstracts are usually published as full articles in academic journals after an academic conference. Including an abstract could cause a duplication of the original research data. (vii) The articles dealing with male breast cancer were excluded. Only articles dealing with female breast cancer were included. (viii) Several articles were included additionally after the screening and review of the bibliographies of essential articles.

The first and corresponding author, JM, and the third author, YM, conducted the selection process separately. After this process, two selection results were compared with each other, and these two authors discussed them. Under this discussion, a final selection result was decided.

Exposure, outcome, and confounding aspect of each study

The authors carefully examined each study from the perspective of selection, exposure, and outcome biases and confounding. The results of this examination were summarized in separate tables. Based on these results, the overall reliability of a study was assessed.

Data extraction

Risk estimates from each study were extracted to construct the dose-response meta-analysis dataset. For the construction of a dose-response relationship, each risk estimate for each dose category of night shift work exposure was extracted. The dose of interest in this study was the years of night shift work.

Examination of publication bias

The existence of publication bias was examined using Begg’s funnel plot and Egger’s regression test. If Begg’s funnel plot shows an asymmetric shape, the existence of a publication bias was suspected. Egger’s regression test uses the precision and the standardized effect size of the effect estimate from a study as the independent variable and dependent variable, respectively [14]. If Egger’s regression test result shows a statistically significant result, the existence of a publication bias could be suspected. The statistically significant p-value for publication bias was set at 0.05.

For Egger’s regression test, only one representative effect estimate (for example, RR for cohort studies or OR for case-control studies) is needed for each study. Therefore, the authors applied the same two-stage dose-response meta-analysis method used in this study (will be explained in subsection 2.6) to each study separately [9, 10]. Then, the authors calculated a representative RR or OR of breast cancer for one year increase in night shift work from each study. These RRs or ORs and calculated variance were used to conduct Egger’s regression test.

Dose-response meta-analyses

For the investigation of the dose-response relationship between the years of night shift work (exposure dose) and the incidence of breast cancer (response), a two-stage dose-response meta-analysis was applied [9, 10].

First, the authors calculated a point dose for each dose range of exposure (years of night shift work). For a finite range with a lower and upper limit, we applied the median value for the range. For the highest dose range category, we added the half value of the interval for other dose ranges to the lower limit of the highest category. For example, if the dose ranges are comprised of 0, 0–10, 10–20, 20–30, and > 30, we assigned 0, 5, 15, 25, and 35 (30+(10/2)) as the point doses.

Second, we applied the two-stage dose-response meta-analysis methodology [10]. This process is composed of two stages. The first stage is to estimate the dose-response association between the adjusted log risk ratios and the levels of a specific exposure (point dose) in a particular study. The linear regression model is.

graphic file with name M1.gif 1

where the dependent variable y is an n×1 vector of log relative risks (not including the reference one), and X is a n×p matrix containing the non-referent values of the dose and/or some transforms of it (e.g., splines, polynomials). The variance-covariance matrix COV(ε) is equal to the following symmetric matrix.

graphic file with name M2.gif 2

where the covariance among (log) risk ratios implies the non-diagonal elements of S are unlikely to be equal to zero. For the covariance approximation, the authors applied a method devised by Greenland and Longnecker. The second stage is to combine study-specific estimates for the estimation of the trend. Each study included in the dose-response meta-analysis can be expressed as.

graphic file with name M3.gif 3

where Inline graphic = Inline graphic. The marginal model defined in Eq. 3 has independent within-study and between-study components. In the between-study components, Inline graphic is assumed to be sampled from Inline graphic, where ψ is the unknown between-study covariance matrix. Here, β can be interpreted as the population-average outcome parameters, namely the coefficients defining the pooled dose-response trend. The prediction of interest in a dose-response analysis is the relative risk for the disease comparing two exposure values. Given a range of exposure x and a chosen reference value Inline graphic, the predicted pooled dose-response association can be obtained as follows

graphic file with name M9.gif 4

where X and Inline graphic are the design matrices evaluated, respectively, in x and Inline graphic. A (1-α/2) % confidence interval for the predicted pooled dose-response curve is given by

graphic file with name M12.gif 5

where Inline graphic is the estimated covariance matrix of Inline graphic

A dose-response meta-analysis was conducted two times, using all studies and only reliable studies, respectively.

Statistical software

For all statistical analyses, R software version 4.2.2 was used. For a dose-response meta-analysis, the R package ‘dosresmeta’ was used [10].

Results

Literature search and screening

Application form for systematic search is provided in Supplementary material B. Search terms and used syntax are provided in Supplementary material C. Search results in each of 3 databases are provided in Supplementary material D. The PRISMA flow diagram with grey literature is provided in Fig. 1. In the PubMed, EMBASE, and Cochrane Library, 211, 329, and 85 articles were searched, respectively. Among a total of these 625 articles, 152 articles were duplicated articles. Finally, 473 articles remained.

Fig. 1.

Fig. 1

PRISMA flow diagram with grey literature [15]

Researchers examined the title and abstract of 473 remaining articles. Among these remaining 473 articles, 276 articles were excluded (252 and 21 due to distant topics and animal subjects, respectively), and 197 candidate articles remained. For these 197 candidate articles, the original text was attached and examined (a brief full-text review). Through this step, 109 articles were excluded (82, 13, 7, and 7, due to inclusion criterion (i), (ii), (iii), and (vi), respectively), and 88 articles remained. For these remaining 88 articles, the authors conducted a thorough full-text review and strictly applied the pre-defined eight inclusion criteria for final selection. Through this step, 67 articles were excluded (49, 10, 3, 1, and 4 due to inclusion criteria (i), (ii), (ii), (iv), and (vi), respectively), and 21 articles remained.

Through a careful search of bibliographies of essential articles, the authors could find additional 23 candidate articles. For these 23 candidate articles, the original text was attached and examined (a brief full-text review). Through this step, 13 articles were excluded (9, 3, and 1 due to inclusion criteria (i), (ii), and (iii), respectively), and the other 10 articles remained. For these remaining 10 articles, researchers conducted a thorough full-text review and strictly applied the pre-defined eight inclusion criteria for final selection. Through this step, 5 articles were excluded (4 and 1 due to inclusion criteria (i) and (ii), respectively), and the other 5 articles remained.

Finally, 10 cohort study articles and 16 case-control study articles were included. For these 26 included articles, 12 cohort, and 16 case-control reports were included.

Characteristics of included studies

Table 1 provides the characteristics of 10 cohort studies that were included (12 reports). The total number of cases and person-years were 18,086 cases and 7,987,557 person-years, respectively. The study year for cohort construction starts in 1959, and the specific data extraction and analysis were conducted from 1992 to 2014. Three study reports were from the UK and the US, respectively, and another two study reports were from Sweden. One report was from the Netherlands, Canada, China, and Finland, respectively. One report applied dichotomous exposure classification, shift with night versus day shifts [18]. The longest range for years of night shift work was from 0 to 45 years, and the shortest range for years of night shift work was from 0 to > 10 years. The longest range for point dose (years of night shift work) was from 0 to 37.5 years, and the shortest range for point dose was from 0 to 9. The highest RR reported was 1.79 (95% CI 1.06–3.01) for the category of > 20 years compared to no night shift work in Schernhammer et al. (2006) [25]. The lowest RR reported was 0.69 (95% CI 0.20–2.41) for the category of 5–9 years compared to no night shift work in Harma et al. (2022) [24].

Table 1.

Characteristics of cohort studies

Authors Report distinction Study year Study country Study name Years of night shift work (range) Years of night shift work (point dose) Breast cancer cases
(total cases: 18,086)
Person-years
(total person-years: 7,987,557)
RR and 95% confidence interval (CI)
Akerstedt et al. (2015) [16] 1 1959, 1998–2003 Sweden Screening Across the Lifespan Twin (SALT) study 0 0 354 84,163 1
1–5 2.5 57 14,537 0.93 (0.66–1.31)
6–10 7.5 16 5559 0.79 (0.45–1.38)
11–20 15 18 5341 0.8 (0.45–1.42)
21–45 32.5 18 2653 1.77 (1.03–3.04)
Jones et al. (2019) [17] 2 2003–2014 UK Generation study 0 0 1845 249,864 1
0–10 5 89 102,298 0.92 (0.74–1.14)
10–20 15 65 192,878 1.09 (0.85–1.4)
20–30 25 36 241,610 0.97 (0.7–1.35)
> 30 35 24 347,826 1.12 (0.75–1.69)
Knutsson et al. (2013) [18] 3 1992–1995, 1996–1997, 2000–2003, 2009 Sweden Work, Lipids, and Fibrinogen (WOLF) occupational cohort study Day shifts 0 60 31,136 1
Shift with night

Undetermined

(9.39)

14 6807 2.02 (1.03–3.95)
Koppes et al. (2014) [19] 4 1996–2009 Netherlands Dutch Labor Force Survey 0–3 1.5 684 768,825 1
4–9 6.5 684 582,573 1 (0.9–1.12)
10–19 15 708 413,986 1.07 (0.96–1.19)
> 20 25 455 206,103 1.11 (0.98–1.26)
McNeil et al. (2020) [20] 5 2004, 2008, 2018 Canada Alberta’s Tomorrow Project 0 0 258 101,376 1
0.1–5.9 3 64 27,775 0.92 (0.7–1.21)
> 6 9 45 16,879 1.02 (0.74–1.41)
Pronk et al. (2010) [21] 6 1996–2000, 2000–2002, 2002–2004, 2004–2007 China Shanghai Women’s Health Study 0 0 423 370,476 1
0–11 5.5 108 95,121 1.1 (0.9–1.3)
11–22 16.5 89 99,504 0.9 (0.7–1.1)
> 22 27.5 97 92,340 1 (0.8–1.3)
Sweeney et al. (2020) [22] 7 2003–2009 US Sister study 0 0 2937 408,668 1
0–5 2.5 88 9540 1.3 (1.05–1.61)
5–10 7.5 30 5271 0.81 (0.57–1.16)
> 10 12.5 42 5973 0.96 (0.71–1.31)
Travis et al. (2016): Million Women Study [23] 8 1996–2001, every 3–4 years, until 2009–2012 UK Million Women Study 0 0 4136 1,170,603 1
0–9 5 400 119,397 0.93 (0.83–1.03)
10–19 15 140 33,152 1.14 (0.96–1.35)
> 20 25 89 24,117 1 (0.81–1.23)
Travis et al. (2016): Epic-Oxford [23] 9 1993–1999 UK Epic-Oxford study 0 0 153 59,795 1
0–9 5 15 5638 1.18 (0.69–2.01)
10–19 15 11 2185 1.92 (1.03–3.57)
> 20 25 1 1475 0.22 (0.03–1.61)
Harma et al. (2022) [24] 10 1997, 2000, 2004, 2008, 2012 Finland Finnish Public Sector study 0 0 10 8759 1
5–9 7.5 4 10,587 0.69 (0.2–2.41)
10–14 12.5 7 6066 1.48 (0.52–4.15)
> 15 17.5 19 7483 1.65 (0.72–3.81)
Schernhammer et al. (2006): NHS2 [25] 11 1989 US Nurses’ Health Study 2 0 0 441 426,119 1
1–9 5 816 809,374 0.98 (0.87–1.1)
10–19 15 80 72,829 0.91 (0.72–1.16)
> 20 25 15 4881 1.79 (1.06–3.01)
Schernhammer et al. (2001): NHS1 [26] 12 1976, every 2 years, 1998 US Nurses’ Health Study 1 0 0 925 298,815 1
1–14 7.5 1324 383,882 1.08 (0.99–1.18)
15–29 22.5 134 40,759 1.08 (0.9–1.3)
> 30 37.5 58 12,559 1.36 (1.04–1.78)

Table 2 provides the characteristics of the included 16 case-control studies (16 reports). The total number of cases, controls, and total participants was 17,805, 21,184, and 38,989, respectively. The study year ranged from 1960 to 1982 to 2015–2019. Two studies did not report the study year [27, 31]. Three studies were from Denmark. Two studies were from the US and China, respectively. One study was reported from Mexico, Australia, Canada, France, Spain, Germany, South Korea, Norway, and Poland, respectively. Four studies applied dichotomous exposure classification, night shift work versus no night shift work [27, 31, 37, 38]. The longest range for years of night shift work was from 0 to 30–39 years, and the shortest range for years of night shift work was from 0 to > 4.5 years. The longest range for point dose (years of night shift work) was from 0 to 37.5 years, and the shortest range for point dose was from 0 to 5.4 years. The highest OR reported was 8.58 (95% CI 2.19–33.78) for the category of ‘night shift work’ compared to ‘no night shift work’ in Bustamante et al. (2019) [27]. The lowest OR reported was 0.32 (95% CI 0.12–0.83) for the category of ≥ 8 years compared to no night shift work in O’Leary et al. (2006) [33].

Table 2.

Characteristics of case-control studies

Authors Report distinction Study name Study year Study country Years of night shift work (range) Years of night shift work (point dose) Cases
(total 17,805 cases)
Controls
(total 21,184 controls)
Total participants
(total 38,989 participants)
OR and 95% CI
Bustamante et al. (2019) [27] 1 ISSEMyM Cancer Center study Not mentioned Mexico No night shift work 0 68 97 165 1
Night shift work

Undetermined

(10.4)

33 4 37 8.58 (2.19–33.78)
Davis et al. (2001) [28] 2 Fred Hutchinson Cancer Research Center study 1992–1995 US 0 0 682 680 1362 1
< 1.0 0.5 19 17 36 1.2 (0.6–2.3)
1.0–3.0 2 20 15 35 1.4 (0.7–2.8)
3.0-4.6 3.8 9 14 23 0.6 (0.3–1.5)
> 4.6 5.4 33 15 48 2.3 (1.2–4.2)
Fritschi et al. (2013) [29] 3 Breast Cancer Employment and Environment Study 2009–2011 Australia 0 0 959 1476 2435 1
< 10 5 140 160 300 1.35 (1.06–1.72)
10–20 15 42 58 100 1.12 (0.74–1.68)
> 20 25 24 40 64 0.96 (0.58–1.61)
Grundy et al. (2013) [30] 4 Vancouver and Kingston study 2005–2010 Canada 0 0 751 773 1524 1
0–14 7.5 283 312 595 0.95 (0.79–1.16)
15–29 22.5 72 81 153 0.93 (0.67–1.3)
> 30 37.5 28 13 41 2.21 (1.14–4.31)
Hansen et al. (2001) [31] 5 Danish cancer study Not mentioned Denmark daytime 0 5847 5723 11,570 1
all night work combined

Undetermined

(4.61)

434 301 735 1.5 (1.3–1.7)
Menegaux et al. (2013) [32] 6 CECILE study 2005–2007 France 0 0 1068 1170 2238 1
< 4.5 2.25 66 69 135 1.12 (0.78–1.6)
> 4.5 6.75 98 78 176 1.4 (1.01–1.92)
O’Leary et al. (2006) [33] 7 Long Island Breast Cancer Study Project 1996–1997 US 0 0 469 473 942 1
< 8 4 11 16 27 0.74 (0.32–1.68)
≥ 8 12 6 19 25 0.32 (0.12–0.83)
Papantoniou et al. (2016) [34] 8 MCC-Spain study 2008–2013 Spain 0 0 1438 1542 2980 1
1–4 2.5 67 58 125 1.21 (0.83–1.76)
5–14 10 103 85 188 1.13 (0.83–1.53)
≥ 15 20 97 91 188 1.21 (0.89–1.65)
Pesch et al. (2010) [35] 9 GENICA study 2000–2004, 2004–2007 Germany 0 0 698 740 1438 1
0–4 2.5 15 25 40 0.64 (0.34–1.24)
5–9 7.5 11 12 23 0.93 (0.41–2.15)
10–19 15 10 11 21 0.91 (0.38–2.18)
≥ 20 25 12 5 17 2.49 (0.87–7.18)
Pham et al. (2019) [36] 10 South Korea NCC study 2012–2018 South Korea 0 0 1561 1541 3102 1
< 10 5 139 145 284 1.07 (0.83–1.36)
> 10 15 21 35 56 1.55 (0.89–2.69)
Wang et al. (2015) [37] 11 Guangzhou cancer study 2010–2012 China night shift work: never 0 443 527 970 1
night shift work: ever

Undetermined

(10.0)

218 187 405 1.37 (1.07–1.74)
Yang et al. (2019) [38] 12 Jiujiang breast cancer study 2013–2016 China night shift work: no 0 360 371 731 1
night shift work: yes

Undetermined

(10.0)

41 30 71 1.38 (1.04–2.71)
Hansen et al. (2012a): Danish military [39] 13 Danish military study 1990–2003 Denmark 0 0 88 361 449 1
1-5.9 3.5 13 67 80 0.9 (0.4–1.7)
6-14.9 10.5 18 48 66 1.7 (0.9–3.2)
> 15 19.5 12 29 41 2.1 (1-4.5)
Lie et al. (2006) [40] 14 Norwegian nurse study 1960–1982 Norway 0 0 50 215 265 1
0–14 7.5 362 1511 1873 0.95 (0.67–1.33)
15–29 22.5 101 359 460 1.29 (0.82–2.02)
≥ 30 37.5 24 58 82 2.21 (1.1–4.45)
Szkiela et al. (2021) [41] 15 Lodz region study 2015–2019 Poland 0 0 310 410 720 1
1–9 5 19 17 36 1.48 (0.76–2.89)
10–19 15 74 31 105 3.16 (2.02–4.92)
20–29 25 44 20 64 2.91 (1.68–5.04)
30–39 35 27 14 41 2.55 (1.32–4.95)
Hansen et al. (2012b): Danish nurse [42] 16 Danish nurse study 2001–2003 Denmark Graveyard shifts: 0 0 37 252 289 1
1–5 2.5 55 228 283 1.5 (0.99–2.5)
5–10 7.5 70 195 265 2.3 (1.4–3.5)
10–20 15 66 236 302 1.9 (1.1–2.8)
≥ 20 25 39 124 163 2.1 (1.3–3.2)

Supplementary material E provides point dose estimates (years of night shift work) for studies with dichotomous exposure classification, night shift work versus no night shift work. The rationale for these calculations is co-provided (main texts and calculation).

Exposure, outcome, and confounding aspects of each study

Supplementary material F summarized the selection, exposure, outcome, and confounding aspects of each study, which were extracted from the main texts of each study. Table 3 and 4 provide a summary table of special features for each study from the perspective of exposure, outcome, and confounding. In addition, the overall reliability of each study is provided in the rightmost column of these tables. Table 3 and 4 are for cohort and case-control studies, respectively. For selection bias, all studies did not have any special features related to this aspect. Therefore, we omitted the column for selection bias in Table 3 and 4.

Table 3.

Exposure, outcome, and confounding aspect of each study (cohort studies)

Authors Report distinction Exposure (definition of night shift work, assessment method) Outcome (definition of breast cancer) Confounding Overall reliability
Akerstedt et al. (2015) [16] 1

Word definition

‘worked night’

Incident breast cancer Typical covariates Reliable
Jones et al. (2019) [17] 2

10 pm to 7 am

Detailed questionnaires

Incomplete exposure assessment for night shift work that ended before the last 10-year period*

Incident breast cancer

Typical covariates

Time-varying covariates

Unreliable*
Knutsson et al. (2013) [18] 3

22:00–06:00

Only dichotomous categorization: shift with night versus day*

Incident breast cancer Only two confounding variables in the final model: number of children and alcohol intake (However, after careful statistical examination) Unreliable*
Koppes et al. (2014) [19] 4 Midnight to 6 am Admission due to breast cancer Typical covariates Reliable
McNeil et al. (2020) [20] 5

Word definition

‘Rotated with nights’

‘Straight night shifts’

Incident breast cancer Typical covariates Reliable
Pronk et al. (2010) [21] 6 ‘Starting work after 10 PM at least 3 times a month for over 1 year’ Incident breast cancer Typical covariates Reliable
Sweeney et al. (2020) [22] 7

Night: ≥1 h between 12:00– 2:00 AM

Rotating shift

Incident breast cancer (including ductal carcinoma in situ) Typical covariates Reliable
Travis et al. (2016): Million Women Study [23] 8

Midnight to 6:00

At least 3 nights per month

Incident breast cancer (invasive) and death due to breast cancer Typical covariates Reliable
Travis et al. (2016): Epic-Oxford [23] 9

Word definition

‘night shifts’

‘at least one night per month or 12 nights per year’

Incident breast cancer (invasive) and death due to breast cancer Typical covariates Reliable
Harma et al. (2022) [24] 10 Recent definition of the IARC working group for night shift work Incident breast cancer Typical covariates Reliable
Schernhammer et al. (2006): NHS2 [25] 11

Word definition

‘rotating night shifts for at least 3 nights per month’

Incident breast cancer Typical covariates Reliable
Schernhammer et al. (2001): NHS1 [26] 12

Word definition

‘rotating night shifts for at least 3 nights per month’

Incident breast cancer Typical covariates Reliable

*The main reason why the study was rated ‘unreliable’

Table 4.

Exposure, outcome, and confounding aspect of each study (case-control studies)

Authors Report distinction Exposure (definition of night shift work, assessment method) Outcome (definition of breast cancer) Confounding Overall reliability
Bustamante et al. (2019) [27] 1

9 pm to 7 am

At least one year

Only dichotomous categorization: night shift work vs. no night shift work*

Incident breast cancer Typical covariates Unreliable*
Davis et al. (2001) [28] 2

‘graveyard shift’

Specific start and stop times in defining each shift

Incident breast cancer Typical covariates Reliable
Fritschi et al. (2013) [29] 3

Midnight to 5 am: graveyard shift

Rather simple: the main focus is not night shift work, but sleep pattern.*

Incident invasive breast cancer, excluding ductal carcinoma in situ Typical covariates (severely simple) Unreliable*
Grundy et al. (2013) [30] 4

23:00 to 7:00

Night shift jobs

Incident in situ or invasive breast cancer Typical covariates Reliable
Hansen et al. (2001) [31] 5

Not mentioned

‘night time work’

Only dichotomous categorization: all night work combined vs. day time work*

Incident breast cancer Typical covariates (rather simple) Unreliable*
Menegaux et al. (2013) [32] 6

11:00 pm to 5:00 am

Night shift (overnight)

Incident breast cancer Typical covariates Reliable
O’Leary et al. (2006) [33] 7

Overnight shift

7:00 pm to the following morning

Incident in situ or invasive breast cancer Typical covariates Reliable
Papantoniou et al. (2016) [34] 8

Not mentioned

‘shift type (day, night, rotating)’

Incident breast cancer Typical covariates Reliable
Pesch et al. (2010) [35] 9

24:00 to 5:00

night shifts

Incident breast cancer Only three confounding variables in the final model: family history of breast cancer, hormone therapy use, and number of mammograms (However, after careful statistical examination) Reliable
Pham et al. (2019) [36] 10

09:00 pm to 08:00 am

Night shifts regularly for at least 2 months

Incident breast cancer Typical covariates Reliable
Wang et al. (2015) [37] 11

Midnight to 06:00 am

Night shift work

Only dichotomous categorization: ever vs. never night shift worker*

Incident breast cancer Typical covariates Unreliable*
Yang et al. (2019) [38] 12

Not mentioned

Only dichotomous categorization: ever vs. never night shift worker*

Incident invasive breast cancer Typical covariates Unreliable*
Hansen et al. (2012a): Danish military [39] 13

17:00 to 09:00

Night shift work

Incident breast cancer Typical covariates Reliable
Lie et al. (2006) [40] 14

Rotating night shifts

Nurse study

Incident breast cancer Only two confounding variables in the final model: employment time as a nurse and parity Reliable
Szkiela et al. (2021) [41] 15

Word definition

‘night shift’

Incident breast cancer Typical covariates Reliable
Hansen et al. (2012b): Danish nurse [42] 16 Graveyard shifts: 19:00 to 09:00 Incident breast cancer Typical covariates Reliable

*The main reason why the study was rated ‘unreliable’

For cohort studies, two studies were rated unreliable. Jones et al. (2019) was rated unreliable because of incomplete exposure assessment for night shift work that ended before the last 10-year period from the start of the study [17]. Knutsson et al. (2013) was rated unreliable because of only dichotomous categorization for night shift work: ‘shift with night versus day [18]. The total number of cases and person-years for reliable studies were 15953 cases and 6812138 person-years, respectively.

Five case-control studies were rated unreliable. Bustamante et al. (2019) was rated unreliable because of only dichotomous exposure categorization: night shift work versus no night shift work [27]. Fritschi et al. (2013) was rated unreliable because the exposure assessment for night shift work was rather simple. The main exposure of interest was sleep patterns and not night shift work [29]. Hansen et al. (2001) was rated unreliable because of only dichotomous categorization: all night work combined versus daytime work [31]. Wang et al. (2015) was rated unreliable because of only dichotomous categorization of night shift work exposure: ever versus never night shift worker [37]. Yang et al. (2019) was rated unreliable because of only dichotomous exposure categorization: ever versus never night shift worker [38]. The total number of cases, controls, and total participants for reliable studies was 9196, 12,210, and 21,406, respectively.

Publication bias

Figure 2 provides each Begg’s funnel plot for cohort studies and case-control studies, respectively. The points in each funnel plot showed a relatively symmetric distribution (low possibility of publication bias). Supplementary material G provided the representative RRs and ORs calculated from each study using the same dose-response meta-analysis method used in this study. The Egger’s regression test result for cohort studies and case-control studies showed a p-value of 0.1437 and 0.1430, respectively. Based on these results, we concluded that the possibility of publication would be low.

Fig. 2.

Fig. 2

Begg’s funnel plot for cohort and case-control studies

Dose-response meta-analysis

Table 5 Provides the results of the dose-response meta-analyses for only reliable studies. First, the dose-response meta-analysis model for cohort studies and case-control studies was statistically significant with a p-value of 0.0035 and 0.0001, respectively. The pooled RR of female breast cancer (from cohort studies) for 1, 10, 20, and 30 years of night shift work exposure was 1.0042 (95% CI 1.0014–1.0070), 1.0425 (95% CI 1.0138–1.0719), 1.0867 (95% CI 1.0278–1.1490), and 1.1328 (95% CI 1.0419–1.2317), respectively. The pooled OR of female breast cancer (from case-control studies) for 1, 10, 20, and 30 years of night shift work exposure was 1.0213 (95% CI 1.0108–1.0319), 1.2346 (95% CI 1.1129–1.3695), 1.5242 (95% CI 1.2386–1.8756), and 1.8817 (95% CI 1.3784–2.5687), respectively. Figure 3 provides each dose-response meta-analysis plot for cohort studies and case-control studies, respectively, using only reliable studies. Supplementary material H provides the results of the dose-response meta-analyses for all studies and the dose-response meta-analysis plot for all cohort and case-control studies.

Table 5.

Results of dose-response meta-analyses for only reliable studies

Study type Years of night shift work
1 year 10 years 20 years 30 years
Pooled RR (cohort studies) and pooled OR (case-control studies) for female breast cancer (95% CI)
Cohort studies 1.0042 (1.0014–1.0070) 1.0425 (1.0138–1.0719) 1.0867 (1.0278–1.1490) 1.1328 (1.0419–1.2317)
Case-control studies 1.0213 (1.0108–1.0319) 1.2346 (1.1129–1.3695) 1.5242 (1.2386–1.8756) 1.8817 (1.3784–2.5687)

Fig. 3.

Fig. 3

Dose-response meta-analysis plot for only reliable cohort (upper figure) and case-control studies (lower figure). The blue line is a continuous line of risk estimates along the increasing exposure (years of night shift work). Dashed lines are upper and lower bounds of 95% confidence intervals for risk estimates. Model: two-stage dose-response meta-analysis [9, 10]

Discussion

In this dose-response meta-analysis study, reliable 10 cohort and 11 case-control reports were included. Egger’s regression test result indicated that the possibility of publication bias is low. The risk of breast cancer increased by 0.42, 4.25, 8.67, and 13.28% after 1, 10, 20, and 30 years of night shift work exposure, respectively, according to cohort studies. The risk of breast cancer increased by 2.13, 23.46, 52.42, and 88.17% after 1, 10, 20, and 30 years of night shift work exposure, respectively, according to case-control studies.

Review of previous meta-analyses

The following studies are recent systematic review and meta-analysis studies on the relationship between night shift work. Recent works are essential because they tried to synthesize all available evidence from individual articles published until the most recent days.

Van et al. concluded that night shift work is not associated with a risk of breast cancer [1]. In this study, only the case-control study group showed a statistically significant increased risk of breast cancer for ever night shift work versus never night shift work (pooled OR of 1.34, 95% CI 1.17–1.53). The pooled risk estimate for the nested case-control study group (pooled OR of 1.14, 95% CI 0.89–1.46) and that for the cohort study group (pooled RR of 0.98, 95% CI 0.93–1.03) were statistically insignificant for ever night shift work versus never night shift work. However, this study treated OR and RR as the same risk estimate and combined these two different types of risk estimates without any valid conversion. As seen in our results, the ORs from case-control studies tend to be higher than the RRs from cohort studies. This difference is also distinct in this study. Strictly speaking, OR can be converted into RR if the non-exposed prevalence for each OR is given [43]. In addition, this study did not consider a dose-response relationship between the years of night shift work and the risk of breast cancer. Only one risk estimate was extracted from each study, and this single estimate was used to represent the individual study. However, in occupational health and environmental health, a correct exposure assessment and consideration of dose-response relationship are essential keys for correct risk definition. Contrary to this study, the authors applied a reliable two-stage dose-response meta-analysis methodology to utilize multiple exposure doses and corresponding risk estimates reported in each individual article.

Manouchehri et al. concluded the pooled RR and 95% CI of breast cancer for < 10 years of night shift work was 1.13 (95% CI 1.03–1.24), and that for ≥ 10 years of night shift work was 1.08 (95% CI 0.99–1.17) [2]. In particular, studies with high quality and those adjusted for reproductive factors and family history of breast cancer showed an increased risk of breast cancer for night shift workers with statistical significance. This study classified the period of night shift work exposure into two categories: <10 years and ≥ 10 years of night shift work. However, the ≥ 10 years group showed a statistically insignificant increased risk, and < 10 years group showed a statistically significant increased risk. The statistically insignificant result for ≥ 10 years of night shift work could be due to a healthy worker survivor effect.

Dun et al. also reported that night shift work is not associated with the risk of breast cancer (pooled OR of 1.009, 95% CI 0.984–1.033) in a meta-analysis study [44].

Examination of publication bias in a two-stage dose-response meta-analysis

In this study, the authors conducted Egger’s regression test using the representative RRs or ORs calculated by applying the same dose-response meta-analysis method to the effect estimates from each individual study separately. This method was devised by the authors, and further discussion is needed on this methodology. The authors will publish a methodology paper on this methodology with various examples, including the one from this study.

Strengths and limitations of this study

Until today, the papers and meta-analysis papers indicated somewhat incompatible results on the association between night shift work exposure and female breast cancer incidence. This was because of (i) non-strict and non-transparent application of inclusion criteria for meta-analysis, (ii) misunderstanding of some essential differences between effect estimates obtained from different types of study design (for example, RRs and ORs), (iii) inaccurate exposure assessment in original studies or the application of inaccurate exposure dose in the meta-analysis, and (iv) the primitive evidence synthesis methods applied for the investigation of a dose-response relationship. On the contrary, this study (i) strictly applied eight transparent inclusion criteria, and (ii) thoroughly separated RRs from cohort studies and ORs from case-control studies and synthesized each type of effect estimates separately. In addition, (iii) exposure dose (years of night shift work) was clearly defined in evidence synthesis based on the years of night shift work reported in individual studies. Finally, (iv) the authors applied a reliable two-stage dose-response meta-analysis method reported in recent literature [9, 10].

Another strength of this study is a thorough review of previous studies regarding selection, exposure, outcome, and confounding aspects. Based on this thorough review process, the authors carefully excluded unreliable two cohort and five case-control studies from the initially included studies. This process enhanced the reliability of the results.

On the contrary, this study also has several limitations. First, this study separated cohort studies from case-control studies. However, under the rare disease assumption, the ORs acquired from case-control studies can be regarded as RRs acquired from cohort studies for rare diseases such as breast cancer [43]. The decision to separate these two types of studies was based on relatively lower risk estimates acquired from cohort studies than those from case-control studies. In future studies, the reason why the risk estimates from case-control studies are generally higher than those from cohort studies should be investigated further, and the risk estimates from case-control studies should be incorporated to those from cohort studies. Second, even though the authors analyzed the selection, exposure, outcome, and confounding aspects of each study, there would have been a remaining inter-study variation in the dose-response meta-analysis. In the future, if a cohort study with a far larger number of participants was conducted, a more conclusive result could be ascertained. Third, there is a possibility of survivorship bias. For example, women with 30 years of night shift work history should have survived at least 30 years after the start of night shift work to be included in this study as a 30-year night shift worker. Because the studies included in this meta-analysis defined the outcome as the incidence of or admission due to breast cancer, other causes of death except for breast cancer could have introduced this bias if the incidence rate of breast cancer had been different between dead night shift workers due to other causes and study participants. In future studies, this possibility should be considered. Fourth, environmental factors such as exposure to environmental estrogens or comorbidities such as type 2 diabetes mellitus and obesity may have contributed to the overall risk of breast cancer. Even though each included study adjusted for various potential confounders, it might have been difficult to consider confounders such as environmental estrogens or the use of personal care products (containing hormone disruptors) in these previous studies. These potential confounders should be considered in future studies.

Conclusion

The risk of breast cancer increased by 0.42, 4.25, 8.67, and 13.28% after 1, 10, 20, and 30 years of night shift work exposure, respectively, according to a dose-response meta-analysis of 10 reliable cohort studies. The risk of breast cancer increased by 2.13, 23.46, 52.42, and 88.17% after 1, 10, 20, and 30 years of night shift work exposure, respectively, according to a dose-response meta-analysis of 11 reliable case-control studies. This study has several strengths from the perspective of a dose-response meta-analysis: Strictly applied eight inclusion criteria, separately synthesized RRs from cohort studies and ORs from case-control studies, clearly defined exposure dose, years of night shift work for each risk estimate, a reliable dose-response meta-analysis methodology, and careful considering of selection, exposure, and outcome biases and confounder adjustment for each study. This careful consideration of potential biases and confounding led to the exclusion of unreliable two cohort and five case-control studies.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1 (821.2KB, pdf)

Acknowledgements

The authors appreciate the efforts of Minji Kim, an information specialist in the medical library of Inha University, Incheon, South Korea.

ORCID ID: 0000-0002-1951-0583.

NAME: Minji Kim.

Address: Medical Library, Inha University Hospital, Inhang-ro 27, Jung-gu, Incheon, 22332 Republic of Korea.

Telephone: +82-32-890-2643.

Email: mjkim0311@inhauh.com.

Author contributions

Authors contributionJinyoung Moon: Conceptualization, Resources, Data Curation, Software, Writing – Original Draft, Visualization, Supervision, Project administrationAtsuko Ikeda-Araki: Writing – Review & Editing, Methodology, ValidationYongseok Mun: Investigation, Formal analysis.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Data availability

All data generated or analyzed during this study are included in this published article.

Declarations

Ethics approval and consent to participate

The authors confirm that all experiments were performed in accordance with the Declaration of Helsinki.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Authors open researcher and Contributor ID (ORCID)

Jinyoung Moon: https://orcid.org/0000-0001-5948-823X.

Atusko Ikeda-Araki: https://orcid.org/0000-0002-3065-262X.

Yongseok Mun: https://orcid.org/0000-0003-0123-0361.

Registration information for meta-analysis

This dose-response meta-analysis was not registered. However, the authors can provide any information regarding the process of evidence synthesis upon request.

Protocol information

The protocol for this dose-response meta-analysis was not prepared. However, the authors can provide any information regarding the process of evidence synthesis upon request.

Footnotes

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Van NTH, Hoang T, Myung SK. Night shift work and breast cancer risk: a meta-analysis of observational epidemiological studies. Carcinogenesis. 2021;42(10):1260–9. 10.1093/carcin/bgab074 [DOI] [PubMed] [Google Scholar]
  • 2.Manouchehri E, Taghipour A, Ghavami V, Ebadi A, Homaei F, Latifnejad Roudsari R. Night-shift work duration and breast cancer risk: an updated systematic review and meta-analysis. BMC Womens Health. 2021;21(1):89. 10.1186/s12905-021-01233-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.IARC_Working_Group_on_the_Identification_of_Carcinogenic_Hazards_to_Humans. IARC Monographs on the Identification of Carcinogenic Hazards to Humans. In: Lyon FR (ed.) Night shift work edn. International Agency for Research on Cancer © International Agency for Research on Cancer, 2020. For more information contact publications@iarc.fr.; 2020.
  • 4.National_Toxicology_Program. NTP cancer hazard assessment report on night shift work and light at night. edn. Research Triangle Park (NC): National Toxicology Program; 2021. [PubMed] [Google Scholar]
  • 5.Haus EL, Smolensky MH. Shift work and cancer risk: potential mechanistic roles of circadian disruption, light at night, and sleep deprivation. Sleep Med Rev. 2013;17(4):273–84. 10.1016/j.smrv.2012.08.003 [DOI] [PubMed] [Google Scholar]
  • 6.Urbano T, Vinceti M, Wise LA, Filippini T. Light at night and risk of breast cancer: a systematic review and dose-response meta-analysis. Int J Health Geogr. 2021;20(1):44. 10.1186/s12942-021-00297-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Flynn-Evans EE, Stevens RG, Tabandeh H, Schernhammer ES, Lockley SW. Total visual blindness is protective against breast cancer. Cancer Causes Control. 2009;20(9):1753–6. 10.1007/s10552-009-9405-0 [DOI] [PubMed] [Google Scholar]
  • 8.Pukkala E, Ojamo M, Rudanko S-L, Stevens RG, Verkasalo PK. Does incidence of breast Cancer and prostate Cancer decrease with increasing degree of visual impairment. Cancer Causes Control. 2006;17(4):573–6. 10.1007/s10552-005-9005-6 [DOI] [PubMed] [Google Scholar]
  • 9.Berlin JA, Longnecker MP, Greenland S. Meta-analysis of epidemiologic dose-response data. Epidemiology. 1993;4(3):218–28. 10.1097/00001648-199305000-00005 [DOI] [PubMed] [Google Scholar]
  • 10.Crippa A, Orsini N. Multivariate Dose-Response Meta-Analysis: the dosresmeta R Package. J Stat Softw Code Snippets. 2016;72(1):1–15. [Google Scholar]
  • 11.Diaz-Quijano FA. A simple method for estimating relative risk using logistic regression. BMC Med Res Methodol. 2012;12(1):14. 10.1186/1471-2288-12-14 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Lee J, Chia KS. Estimation of prevalence rate ratios for cross sectional data: an example in occupational epidemiology. Occup Environ Med. 1993;50(9):861–2. 10.1136/oem.50.9.861 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Nijem K, Kristensen P, Al-Khatib A, Bjertness E. Application of different statistical methods to estimate relative risk for self-reported health complaints among shoe factory workers exposed to organic solvents and plastic compounds. Norsk Epidemiologi. 2009;15(1).
  • 14.Sterne JAC, Becker BJ, Egger M. The Funnel Plot. In: Publication bias in meta-analysis edn.; 2005, pp. 73–98.
  • 15.Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. 10.1136/bmj.n71 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Akerstedt T, Knutsson A, Narusyte J, Svedberg P, Kecklund G, Alexanderson K. Night work and breast cancer in women: a Swedish cohort study. BMJ Open. 2015;5(4):e008127–008127. 10.1136/bmjopen-2015-008127 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Jones ME, Schoemaker MJ, McFadden EC, Wright LB, Johns LE, Swerdlow AJ. Night shift work and risk of breast cancer in women: the generations Study cohort. Br J Cancer. 2019;121(2):172–9. 10.1038/s41416-019-0485-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Knutsson A, Alfredsson L, Karlsson B, Åkerstedt T, Fransson EI, Westerholm P, Westerlund H. Breast cancer among shift workers: results of the WOLF longitudinal cohort study. Scand J Work Environ Health. 2013;39(2):170–7. 10.5271/sjweh.3323 [DOI] [PubMed] [Google Scholar]
  • 19.Koppes LLJ, Geuskens GA, Pronk A, Vermeulen RCH, De Vroome EMM. Night work and breast cancer risk in a general population prospective cohort study in the Netherlands. Eur J Epidemiol. 2014;29(8):577–84. 10.1007/s10654-014-9938-8 [DOI] [PubMed] [Google Scholar]
  • 20.McNeil J, Heer E, Willemsen RF, Friedenreich CM, Brenner DR. The effects of shift work and sleep duration on cancer incidence in Alberta`s Tomorrow Project cohort. Cancer Epidemiol. 2020;67:101729. 10.1016/j.canep.2020.101729 [DOI] [PubMed] [Google Scholar]
  • 21.Pronk A, Ji BT, Shu XO, Xue S, Yang G, Li HL, Rothman N, Gao YT, Zheng W, Chow WH. Night-shift work and breast cancer risk in a cohort of Chinese women. Am J Epidemiol. 2010;171(9):953–9. 10.1093/aje/kwq029 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Sweeney MR, Sandler DP, Niehoff NM, White AJ. Shift work and working at night in relation to breast cancer incidence. Cancer Epidemiol Biomarkers Prev. 2020;29(3):687–9. 10.1158/1055-9965.EPI-19-1314 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Travis RC, Balkwill A, Fensom GK, Appleby PN, Reeves GK, Wang X-S, Roddam AW, Gathani T, Peto R, Green J, et al. Night shift work and breast cancer incidence: three prospective studies and meta-analysis of published studies. J Natl Cancer Inst. 2016;108(12):djw169. 10.1093/jnci/djw169 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Harma M, Ojajarvi A, Koskinen A, Lie JA, Hansen J. Shift work with and without night shifts and breast cancer risk in a cohort study from Finland. Occupational Environ Med. 2022. [DOI] [PMC free article] [PubMed]
  • 25.Schernhammer ES, Kroenke CH, Laden F, Hankinson SE. Night work and risk of breast cancer. Epidemiology. 2006;17(1):108–11. 10.1097/01.ede.0000190539.03500.c1 [DOI] [PubMed] [Google Scholar]
  • 26.Schernhammer ES, Laden F, Speizer FE, Willett WC, Hunter DJ, Kawachi I, Colditz GA. Rotating night shifts and risk of breast cancer in women participating in the nurses’ health study. J Natl Cancer Inst. 2001;93(20):1563–8. 10.1093/jnci/93.20.1563 [DOI] [PubMed] [Google Scholar]
  • 27.Bustamante-Montes LP, Flores-Meza B, Hernández-Valero MA, Cárdenas-López A, Dolores-Velázquez R, Borja-Bustamante P, Borja-Aburto VH. Night shift work and risk of breast Cancer in women. Arch Med Res. 2019;50(6):393–9. 10.1016/j.arcmed.2019.10.008 [DOI] [PubMed] [Google Scholar]
  • 28.Davis S, Mirick DK, Stevens RG. Night shift work, light at night, and risk of breast cancer. JNCI: J Natl Cancer Inst. 2001;93(20):1557–62. 10.1093/jnci/93.20.1557 [DOI] [PubMed] [Google Scholar]
  • 29.Fritschi L, Erren TC, Glass DC, Girschik J, Thomson AK, Saunders C, Boyle T, El-Zaemey S, Rogers P, Peters S, et al. The association between different night shiftwork factors and breast cancer: a case–control study. Br J Cancer. 2013;109(9):2472–80. 10.1038/bjc.2013.544 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Grundy A, Richardson H, Burstyn I, Lohrisch C, SenGupta SK, Lai AS, Lee D, Spinelli JJ, Aronson KJ. Increased risk of breast cancer associated with long-term shift work in Canada. Occup Environ Med. 2013;70(12):831. 10.1136/oemed-2013-101482 [DOI] [PubMed] [Google Scholar]
  • 31.Hansen J. Increased breast Cancer risk among women who work predominantly at night. Epidemiology. 2001;12(1). [DOI] [PubMed]
  • 32.Menegaux F, Truong T, Anger A, Cordina-Duverger E, Lamkarkach F, Arveux P, Kerbrat P, Févotte J, Guénel P. Night work and breast cancer: a population-based case-control study in France (the CECILE study). Int J Cancer. 2013;132(4):924–31. 10.1002/ijc.27669 [DOI] [PubMed] [Google Scholar]
  • 33.O’Leary ES, Schoenfeld ER, Stevens RG, Kabat GC, Henderson K, Grimson R, Gammon MD, Leske MC. Fields ftE, Group BCoLIS: Shift work, light at night, and breast cancer on long island, New York. Am J Epidemiol. 2006;164(4):358–66. 10.1093/aje/kwj211 [DOI] [PubMed] [Google Scholar]
  • 34.Papantoniou K, Castaño-Vinyals G, Espinosa A, Aragonés N, Pérez-Gómez B, Ardanaz E, Altzibar JM, Sanchez VM, Gómez-Acebo I, Llorca J, et al. Breast cancer risk and night shift work in a case–control study in a Spanish population. Eur J Epidemiol. 2016;31(9):867–78. 10.1007/s10654-015-0073-y [DOI] [PubMed] [Google Scholar]
  • 35.Pesch B, Harth V, Rabstein S, Baisch C, Schiffermann M, Pallapies D, Bonberg N, Heinze E, Spickenheuer A, Justenhoven C et al. Night work and breast cancer – results from the German GENICA study. Scand J Work Environ Health 2010(2):134–41. [DOI] [PubMed]
  • 36.Pham T-T, Hwang M, Lee E-S, Kong S-Y, Jung S-Y, Lee S, Kim J, Ha M, Kim S-Y, Park B. Night-shift work and risk of breast cancer in Korean women. Clin Epidemiol. 2019;11:743–51. 10.2147/CLEP.S199521 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Wang P, Ren F-M, Lin Y, Su F-X, Jia W-H, Su X-F, Tang L-Y, Ren Z-F. Night-shift work, sleep duration, daytime napping, and breast cancer risk. Sleep Med. 2015;16(4):462–8. 10.1016/j.sleep.2014.11.017 [DOI] [PubMed] [Google Scholar]
  • 38.Yang W, Shi Y, Ke X, Sun H, Guo J, Wang X. Long-term sleep habits and the risk of breast cancer among Chinese women: a case–control study. Eur J Cancer Prev. 2019;28(4). [DOI] [PubMed]
  • 39.Hansen J, Lassen CF. Nested case–control study of night shift work and breast cancer risk among women in the Danish military. Occup Environ Med. 2012;69(8):551–6. 10.1136/oemed-2011-100240 [DOI] [PubMed] [Google Scholar]
  • 40.Lie J-AS, Roessink J, Kjærheim K. Breast Cancer and night work among Norwegian nurses. Cancer Causes Control. 2006;17(1):39–44. 10.1007/s10552-005-3639-2 [DOI] [PubMed] [Google Scholar]
  • 41.Szkiela M, Kusidel E, Makowiec-Dabrowska T, Kaleta D. How the intensity of night shift work affects breast cancer risk. Int J Environ Res Public Health. 2021;18(9):4570. 10.3390/ijerph18094570 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Hansen J, Stevens RG. Case-control study of shift-work and breast cancer risk in Danish nurses: impact of shift systems. Eur J Cancer. 2012;48(11):1722–9. 10.1016/j.ejca.2011.07.005 [DOI] [PubMed] [Google Scholar]
  • 43.Zhang J, Yu KF. What’s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280(19):1690–1. 10.1001/jama.280.19.1690 [DOI] [PubMed] [Google Scholar]
  • 44.Dun A, Zhao X, Jin X, Wei T, Gao X, Wang Y, Hou H. Association between Night-Shift Work and Cancer Risk: updated systematic review and meta-analysis. Front Oncol. 2020;10:1006. 10.3389/fonc.2020.01006 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary Material 1 (821.2KB, pdf)

Data Availability Statement

All data generated or analyzed during this study are included in this published article.


Articles from BMC Public Health are provided here courtesy of BMC

RESOURCES